Transcenta Holdings Ltd (HKG: 6628) and its U.S. partner Inhibrx Biosciences, Inc. (NASDAQ: INBX) announced...
Sino Medical Sciences Technology Inc. (SHA: 688108) announced European Union regulatory approval for a label...
Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) announced it has received a second indication approval...
Pfizer Inc. (NYSE: PFE) announced positive readouts from a Phase II clinical study evaluating its...
Medtronic plc (NYSE: MDT) announced its intent to acquire SPR Therapeutics, Inc., a privately held...
BeOne Medicines Ltd. (NASDAQ: ONC, HKG: 6160, SHA: 688235), formerly known as BeiGene, Ltd., today...
Bristol-Myers Squibb Company (BMS, NYSE: BMY) announced a strategic agreement with artificial intelligence pioneer Anthropic...
CBC Group, the Singapore-based healthcare private equity firm, and Global Healthcare Opportunities (GHO), the UK-headquartered...
Sanofi SA (NASDAQ: SNY) announced today positive data from the global ElevAATe Phase II clinical...
A federal jury in the U.S. District Court for the District of Massachusetts returned a...
Novartis AG (NYSE: NVS) announced today new data from the PSMAddition Phase III clinical trial...
The China Population Welfare Foundation, in partnership with Lilly (NYSE: LLY) China, unveiled this week...
Hybio Pharmaceutical Co., Ltd. (SHE: 300199) announced today a strategic partnership agreement with two undisclosed...
Shanghai ZJ Bio-Tech Co., Ltd. (SHA: 688317), a leading Chinese molecular diagnostic reagent specialist, announced...
Shandong Buchang Pharmaceuticals Co., Ltd. (SHA: 603858) announced today a comprehensive licensing agreement with fellow...
Bayer AG (ETR: BAYN) announced today that the U.S. Food and Drug Administration (FDA) has...
UCB (EBR: UCB) announced today Week 16 data from the BE BOLD Phase III clinical...
United Laboratories International Holdings Ltd (HKG: 3933) announced today it has received tacit approval from...
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. (HKG: 1541) announced today the dosing of the first patient...
Bio-Thera Solutions (SHA: 688177) announced it has received marketing approval from the U.S. Food and...